The possible explanation for these negative associations is that liver fibrosis progression is a complex process which is affected by many other factors, and ACKR1 is responsible for only 20% of the variation in CCL2 serum levels, which might also restrict its biologic significance in hepatitis C.14 This evidence concerns the gene CCL2 and Hepatic fibrosis.